The 9 per cent rule on shareholder debit balances has been part of Cyprus tax law for fourteen years. Until 31 December 2025 it stopped at the direct shareholder. From 1 January 2026 it reaches the indirect shareholder, the natural person sitting one or several layers above the company whose books show the balance. The amendment to Article 5 of the Income Tax Law N.118(I)/2002 is short, technical, and has been widely under-reported in market coverage of the broader reform package. Same 9 per cent. Same monthly calculation. Same PAYE wrapper. The recipients are the people who used to sit safely behind the holding company.
What changed
Article 5 of the Income Tax Law sets the deemed-benefit charge on debit balances owed by directors, shareholders and related persons to a Cyprus company. The charge is 9 per cent per annum, calculated monthly on the outstanding balance, treated as employment income to the recipient, and remitted by the company through PAYE. The rate, the calculation and the PAYE wrapper are unchanged by the reform. The trade-receivable carve-out is also unchanged. What changed is the perimeter. The reform extends the rule to indirect individual shareholders, natural persons holding the Cyprus company through one or more intermediate corporate entities. The change is in force from 1 January 2026, applies to all balances within its scope on that date regardless of when they arose, and carries no transitional grace period that practitioner commentary has identified.
The amendment was gazetted on 31 December 2025 as part of the package of six tax reform laws voted by the House of Representatives on 22 December. The package as a whole has been discussed at length. The Article 5 change has not. Practitioner coverage typically reduces it to a single bullet, sometimes mis-framed, often without worked examples or any taxonomy of the structures the extension catches.
Who is now caught
The pattern is most easily seen in the most common Cyprus structure. A Cyprus operating company sits beneath a Cyprus holding company; an individual sits above the holding company. A cash advance from the operating company to the individual was, until 31 December 2025, outside Article 5: the individual was not a direct shareholder of the operating company. From 1 January 2026, the individual is an indirect shareholder of the operating company, the deemed benefit accrues on the advance, and the PAYE obligation falls on the operating company rather than on the holding company.
The legacy workaround, interposing a holding company to park the direct-shareholder status above the operating company, no longer does what it used to do.
The same logic runs through any chain. The intermediate vehicle can be a Cyprus or foreign holding company, a fund structure, a joint-venture holding entity, or a multi-tier group. The ultimate individual can be Cyprus-tax-resident or not. The principle does not change: wherever a natural person sits above the Cyprus company through any layer of intermediate vehicle, and that company has a non-trading debit balance with that person, with their spouse, or with a second-degree relative, the deemed benefit accrues from 1 January 2026 and the Cyprus company has the PAYE obligation.
One adjacent point worth flagging, because the question often arises in the same conversation. A loan from a Cyprus operating company to its Cyprus holding company is not within Article 5: the recipient is not a natural person. That balance sits within the transfer pricing regime instead. A loan from the holding company on to the individual above it is then within Article 5 in the ordinary way, as a direct shareholder loan. Where the route through the holding company is built deliberately to layer the corporate vehicle between the operating company's cash and the ultimate individual, the General Anti-Abuse Rule sits in the background and the substance test continues to operate. The rule rewards a structure that is what it appears to be.
The trading carve-out is still there, and still tested
The carve-out is not a get-out. It is a substance test, and the 2026 reform does not change it. Balances that arise out of trade transactions in the ordinary course of the company's business are outside the rule. Cash advances, personal expenses paid by the company, undocumented current-account entries that grow without settlement are inside it. The test attaches to the balance, not to the relationship. A single individual can have, on the company's books, two balances: one a genuine trade receivable on commercial terms, the other a non-trading advance. Only the second engages the 9 per cent.
The Tax Department's substance test, on examination, looks past the accounting label. The narrative offered by the company is tested against the documentary trail and against the business reality. Indicators that support a trading characterisation: the balance arises from invoices issued in the ordinary course of the company's commercial activity; the counterparty is in fact a customer or supplier of the company on commercial terms; the credit period is comparable to what the company extends to or accepts from third parties; the balance turns; the underlying pricing is at arm's length.
Indicators that tip a balance into non-trading: the balance arises from a cash transfer recorded as a receivable; the balance reflects the company paying for personal expenses of the individual or assets used by them; there is no invoice trail; the balance grows over time and is not settled; the arrangement is documented only in a one-line current-account entry. None of these is conclusive in isolation. Taken together they describe a balance the Tax Department is likely to characterise as non-trading on review.
Where the balance is intended to qualify as trading, the file should make the trading character self-evident: contemporary invoicing, terms of trade matched to third-party benchmarks, a bank trail of settlements, consistency with the company's transfer pricing position. The narrative offered after the event carries less weight than a documentary trail laid down at the time.
What the company at the bottom of the chain now needs to do
The operational consequence is the same kind of housekeeping the rule has always required, applied across a wider perimeter. The Cyprus company whose books show the receivable is the one with the PAYE obligation, whether the recipient is a direct shareholder, a director, the spouse or second-degree relative of either, or, from 1 January 2026, the indirect individual at the top of any ownership chain.
Mapping the chain is the first step. For every Cyprus company with material balances on the receivables ledger, the ownership chain is walked to its ultimate individuals. Each natural person at any layer who is, or whose spouse or second-degree relative is, a shareholder or director somewhere in the chain is identified. Every balance the company has with any of those individuals, including current-account entries and informal advances, is captured.
Classification is the second step. Each balance is either a trading balance (carve-out applies; nothing further to do) or a non-trading balance (9 per cent runs from 1 January 2026; PAYE machinery engages). Mixed balances are separated so the trading portion sits clean.
Calculation and reporting is the third step. The 9 per cent is calculated monthly on the outstanding balance. The benefit is added to the recipient's other Cyprus-taxable income for the personal income tax bands. From 1 January 2026 the personal income tax-free band sits at EUR 22,000, raised from EUR 19,500. Cash tax is due only to the extent that the deemed benefit, taken with the recipient's other Cyprus-taxable income, exceeds that threshold. Where the recipient is a non-Cyprus tax resident with no other Cyprus-sourced employment income, the 9 per cent will typically produce a reporting obligation rather than an actual cash tax bill until the running deemed amount crosses EUR 22,000. The reporting obligation itself, however, is absolute. The Cyprus company is required to declare the benefit and run it through PAYE in every case; whether cash tax flows depends on the recipient's overall Cyprus tax position, not on whether the company files.
One subtlety on the payroll side deserves a sentence. Because the deemed benefit is treated as employment income for the personal income tax bands, it is also within scope of the General Healthcare System contribution, applied at the rates that attach to employment income, subject to the annual income cap. Social Insurance and the other employer-side payroll contributions are a more delicate question. For a recipient who is in fact a director or employee of the company, the deemed benefit can pull through into the broader payroll calculations. For an indirect shareholder who holds no director or office-holder role in the company, treating the deemed benefit as employment income is a legal fiction for the purposes of Article 5 only, and the broader payroll suite should not be misapplied. The payroll function needs to be told.
Documentation closes it. The trading carve-out where it applies; the calculation and the PAYE remittance where it does not. The parent article on Cyprus shareholder debit balances walks the year-over-year exposure and the compounding cost of a balance that has gone unaddressed.
What has and has not changed
The 9 per cent rule has not changed in any way that an honest balance owner needs to worry about. The trading carve-out is unchanged. The relatives perimeter is unchanged. The PAYE machinery is unchanged. The rule has changed, however, in every way that mattered to the planner who relied on the interposed holding company to keep the direct-shareholder status above the operating company. The individual at the top of the chain is now in the rule. The Cyprus company at the bottom of the chain has the PAYE obligation. The work between the two is mapping, classification, calculation and the documentary trail.
Each of those is operationally manageable. Discovering an indirect-shareholder balance on Tax Department examination, in 2027 or 2028, on a balance that has been running since the extension came into force, is the alternative.